NCT06201273

Brief Summary

This research focuses on studying the effects of a 12-week exercise program on the health of individuals at risk of heart disease. The program includes High-Intensity Interval Training (HIIT) and Muscle Endurance Resistance Exercise (ERE). The researchers aim to observe the impact of these exercises on physiological adaptability, physical capacity, cardiovascular risk factors, metabolism, body composition, and chronic pain. The participants will be inactive adults with a Body Mass Index (BMI) between 25 and 39.9, who are enrolled in a cardiovascular health program. Individuals with certain serious conditions, such as bone or heart problems, pulmonary diseases, cancer, or those who do not adequately understand instructions or Spanish, are ineligible to participate. Patients will be selected by the program team and divided into three groups: one will perform HIIT, another will engage in ERE, and a control group will continue their usual treatment. Participants will be assessed at different times: before starting, at 4 weeks, at 8 weeks, and at the end of the program. Various health aspects will be measured, including physical activity, quality of life, physical capacity, cardiovascular risk factors, metabolism, body composition, and pain level.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
192

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2023

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 15, 2023

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

December 22, 2023

Completed
20 days until next milestone

First Posted

Study publicly available on registry

January 11, 2024

Completed
19 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2024

Completed
Last Updated

June 13, 2024

Status Verified

June 1, 2024

Enrollment Period

8 months

First QC Date

December 22, 2023

Last Update Submit

June 12, 2024

Conditions

Keywords

ExerciseHigh-Intensity Interval TrainingResistance TrainingInterindividual VariabilityIntraindividual VariabilityPhysiological AdaptationCardiometabolic Risk FactorsPainChronic PainMusculoskeletal PainPain ThresholdPain PerceptionExercise-Induced HypoalgesiaMetabolic FlexibilityIndirect CalorimetryBody CompositionCardiorespiratory FitnessMuscle Strength

Outcome Measures

Primary Outcomes (12)

  • Systolic and Diastolic Blood Pressure

    Pressure in the arteries during and between heartbeats. (mmHg)

    Pre-Intervention: Initial assessment before the training. Week 4: Mid-program evaluation. Week 8: Eight-week assessment. Post-Intervention (Week 12): Final evaluation after 12 weeks.

  • Heart Rate

    Number of heartbeats per minute. (bpm)

    Pre-Intervention: Initial assessment before the training. Week 4: Mid-program evaluation. Week 8: Eight-week assessment. Post-Intervention (Week 12): Final evaluation after 12 weeks.

  • Body Composition

    Percentage of Fat and Lean Mass: Proportion of fat and lean mass in the body. (%)

    Pre-Intervention: Initial assessment before the training. Week 4: Mid-program evaluation. Week 8: Eight-week assessment. Post-Intervention (Week 12): Final evaluation after 12 weeks.

  • Metabolic Flexibility

    Indirect Calorimetry: Measurement of energy expenditure and substrates balance. (kcal)

    Pre-Intervention: Initial assessment before the training. Week 4: Mid-program evaluation. Week 8: Eight-week assessment. Post-Intervention (Week 12): Final evaluation after 12 weeks.

  • Pain Intensity:

    The Chronic Pain Grade Scale is a self-report instrument assessing the intensity and disability associated with chronic pain. It comprises 8 items, 7 of which are in an 11-point Likert format, totaling a range from 0 to 70 points. The final score is derived from summing items 2 to 8. Items 2, 3, and 4 address pain intensity, while items 5, 6, 7, and 8 pertain to disability related to chronic pain. Chronic pain grading based on this scale is classified as: Grade I (low intensity): considering less than 15 points in pain intensity items and less than 17 points in disability items. Grade II (high intensity): 15 points or more in pain intensity items and less than 17 points in disability items. Grade III (moderately limiting): 17 to 24 points in disability items. Grade IV (severely limiting): 25 to 40 points in disability items.

    Pre-Intervention: Initial assessment before the training. Week 4: Mid-program evaluation. Week 8: Eight-week assessment. Post-Intervention (Week 12): Final evaluation after 12 weeks.

  • Pressure Pain Threshold (PPT):

    Pressure Algometer Measurement: Minimum amount of pressure that induces pain. (kg)

    Pre-Intervention: Initial assessment before the training. Week 4: Mid-program evaluation. Week 8: Eight-week assessment. Post-Intervention (Week 12): Final evaluation after 12 weeks.

  • Pain Characterization:

    The characterization of chronic pain will be conducted using questions 15 and 16 (based on the neuropathic pain 4 questionnaire) from the 2013 validated Chilean survey of non-oncological chronic pain. These questions allow for the categorization of pain as either somatic or neuropathic, as detailed below: Somatic Pain: Sharp, widespread (in a nonspecific area), a specific area related to some movement, a squeeze. Neuropathic Pain: Burning, cold pain, electric, tingling, prickling, itching, needle sensation, numbness.

    Pre-Intervention: Initial assessment before the training. Week 4: Mid-program evaluation. Week 8: Eight-week assessment. Post-Intervention (Week 12): Final evaluation after 12 weeks.

  • Handgrip strength

    Handgrip Dynamometry: Measurement of handgrip strength. (kgf or N)

    Pre-Intervention: Initial assessment before the training. Week 4: Mid-program evaluation. Week 8: Eight-week assessment. Post-Intervention (Week 12): Final evaluation after 12 weeks.

  • Cardiorespiratory fitness

    6-minute walk test: The objective is to assess an individual's functional capacity and cardiorespiratory endurance. The primary measurement unit is the distance covered in meters during the 6 minutes

    Pre-Intervention: Initial assessment before the training. Week 4: Mid-program evaluation. Week 8: Eight-week assessment. Post-Intervention (Week 12): Final evaluation after 12 weeks.

  • Fasting Glucose

    Blood glucose level after a fasting period. (mg/dL)

    Pre-Intervention: Initial assessment before the training. Week 4: Mid-program evaluation. Week 8: Eight-week assessment. Post-Intervention (Week 12): Final evaluation after 12 weeks.

  • Glycated Hemoglobin (HbA1c):

    Percentage of glucose-bound hemoglobin in the blood. (%)

    Pre-Intervention: Initial assessment before the training. Week 4: Mid-program evaluation. Week 8: Eight-week assessment. Post-Intervention (Week 12): Final evaluation after 12 weeks.

  • Lipid Profile

    Set of tests to measure cholesterol and triglycerides. (mg/dL)

    Pre-Intervention: Initial assessment before the training. Week 4: Mid-program evaluation. Week 8: Eight-week assessment. Post-Intervention (Week 12): Final evaluation after 12 weeks.

Secondary Outcomes (7)

  • Sociodemographic and Medical Background

    Pre-Intervention: Initial assessment before the training

  • Physical Activity Level

    Pre-Intervention: Initial assessment before the training.

  • Health-related quality of life

    Pre-Intervention: Initial assessment before the training. Week 4: Mid-program evaluation. Week 8: Eight-week assessment. Post-Intervention (Week 12): Final evaluation after 12 weeks.

  • Height

    Pre-Intervention: Initial assessment before the training.

  • Weight

    Pre-Intervention: Initial assessment before the training. Week 4: Mid-program evaluation. Week 8: Eight-week assessment. Post-Intervention (Week 12): Final evaluation after 12 weeks.

  • +2 more secondary outcomes

Study Arms (3)

High-Intensity Interval Training

EXPERIMENTAL

This High-Intensity Interval Training (HIIT) program, structured to span 12 weeks, incorporates three sessions per week. Each session comprises 8 to 10 exercise intervals on a cycle ergometer. During these intervals, participants are required to reach an intensity level between 8 and 10 points, based on the modified Borg scale, which ranges from 1 to 10 points. A typical interval involves 1 minute of intensive pedaling, followed by a 2-minute rest period without any activity. To facilitate progressive development, the resistance of the cycle ergometer will be adjusted biweekly to increase the pedaling challenge. Despite these adjustments, participants should consistently maintain their effort intensity within the 8 to 10 point range on the modified Borg scale for each interval.

Behavioral: High-Intensity Interval Training

Resistance Training

EXPERIMENTAL

This training protocol, spanning a duration of 12 weeks, consists of three weekly sessions. In each session, participants will engage in Elastic Resistance Exercises (ERE) using Theraband elastic bands (CLX). The focus will be on both concentric and eccentric contractions, maintaining an intensity level of 8 to 10 as per the Resistance Exercise Scale (OMNI-RES). Each exercise will be conducted for 1 minute, followed by a 2-minute rest period. Each exercise will be repeated three times within the session. The specific exercises include bicep curls, seated horizontal rows, and wide squats. To ensure proper progression and adaptation, the exercise load will be adjusted biweekly. This adjustment will be based on the physiological adaptations of the subjects to the training, aiming to recalibrate the loads to new resistance thresholds and maintain a consistent intensity of 8 to 10 on the OMNI-RES scale for each exercise.

Behavioral: Resistance Training

Control

NO INTERVENTION

Participants in the control group will be instructed to maintain their current lifestyle and exercise habits throughout the duration of the study. This includes adhering to their prescribed medication regimen as usual.

Interventions

This High-Intensity Interval Training (HIIT) program, structured to span 12 weeks, incorporates three sessions per week. Each session comprises 8 to 10 exercise intervals on a cycle ergometer. During these intervals, participants are required to reach an intensity level between 8 and 10 points, based on the modified Borg scale, which ranges from 1 to 10 points. A typical interval involves 1 minute of intensive pedaling, followed by a 2-minute rest period without any activity. To facilitate progressive development, the resistance of the cycle ergometer will be adjusted biweekly to increase the pedaling challenge. Despite these adjustments, participants should consistently maintain their effort intensity within the 8 to 10 point range on the modified Borg scale for each interval.

High-Intensity Interval Training

This training protocol, spanning a duration of 12 weeks, consists of three weekly sessions. In each session, participants will engage in Elastic Resistance Exercises (ERE) using Theraband CLX elastic bands. The focus will be on both concentric and eccentric contractions, maintaining an intensity level of 8 to 10 as per the OMNI-RES scale. Each exercise will be conducted for 1 minute, followed by a 2-minute rest period. Each exercise will be repeated three times within the session. The specific exercises include bicep curls, seated horizontal rows, and wide squats. To ensure proper progression and adaptation, the exercise load will be adjusted biweekly. This adjustment will be based on the physiological adaptations of the subjects to the training, aiming to recalibrate the loads to new resistance thresholds and maintain a consistent intensity of 8 to 10 on the OMNI-RES scale for each exercise.

Resistance Training

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Physically inactive: Not engaging in 300 minutes of moderate or 150 minutes of vigorous physical activity per week, measured with the IPAQ questionnaire.
  • BMI between 25 and 39.9 kg/m².
  • Belonging to the cardiovascular health program of External Family Health Center Valdivia.
  • Presenting or not presenting chronic non-cancerous pain.

You may not qualify if:

  • Bone disease.
  • Ischemic disease or arrhythmia.
  • Chronic obstructive pulmonary disease (COPD) or asthma.
  • Uncontrolled chronic diseases.
  • Individuals unable to understand instructions.
  • Individuals who do not speak Spanish.
  • History of previous oncological disease or under investigation for suspected neoplastic disease in any part of the body.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universidad San Sebastián

Valdivia, Los Ríos Region, Chile

Location

Related Publications (1)

  • Cano-Montoya J, Rojas Vargas M, Baez Vargas S, Nunez Vergara C, Martinez Huenchullan S, Gallegos F, Alvarez C, Izquierdo M. Impact of resistance and high-intensity interval training on body composition, physical function, and temporal dynamics of adaptation in older women with impaired cardiometabolic health: a randomized clinical trial. BMC Sports Sci Med Rehabil. 2025 Apr 11;17(1):78. doi: 10.1186/s13102-025-01119-0.

MeSH Terms

Conditions

Motor ActivityPainChronic PainMusculoskeletal Pain

Interventions

High-Intensity Interval TrainingResistance Training

Condition Hierarchy (Ancestors)

BehaviorNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMuscular DiseasesMusculoskeletal Diseases

Intervention Hierarchy (Ancestors)

Physical Conditioning, HumanExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaExercise TherapyRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy Modalities

Study Officials

  • Johnattan Cano Montoya

    Universidad San Sebastián

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
The concealment of allocation will be conducted by a researcher not involved in the clinical procedures of the intervention using the method of opaque, sealed, and consecutively numbered envelopes. The random sequence and allocation concealment allow for the control of selection bias. For enhanced bias control, the data analysis will be performed by a researcher blinded to the intervention groups.
Purpose
TREATMENT
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Academic Researcher

Study Record Dates

First Submitted

December 22, 2023

First Posted

January 11, 2024

Study Start

May 1, 2023

Primary Completion

December 15, 2023

Study Completion

January 30, 2024

Last Updated

June 13, 2024

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will not share

Locations